Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00616 |
| Species: | Homo sapiens |
| Position : | chr15:89411868-89412019 |
| Year: | 2022 |
| Title: | The FES Gene at the 15q26 Coronary-Artery-Disease Locus Inhibits Atherosclerosis |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 36321446 |
| MONDO: | |
| Tissue: | Skin |
| Tissue Ontology ID: | UBERON:0000014 |
| Cell Source: | Normal human keratinocytes |
| CVCL ID: | |
| Cell Type: | keratinocyte |
| Cell Ontology ID: | CL:0000312 |
| Experiment Type: | TF binding assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | CRISPR Knockout, CRISPRi, qRT-PCR, Western blot, EMSA |
| Target gene : | FES |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|